Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex Launches Innovative, Industry-Focused Websites

Published: Friday, February 22, 2013
Last Updated: Friday, February 22, 2013
Bookmark and Share
Company builds on award-winning web presence with new digital experience.

Phenomenex Inc. announces an entirely new "Smart Web" design, organized for the key industries the company serves. Redesigned from the ground up, the industry-specific gateways function as complete digital consultants, helping users find answers by providing customized content and newsletters along with product selection and method development tools.

Already recognized as an innovator in web design, Phenomenex has created the new industry sites to address overall user movement toward researching, purchasing and applying products completely with web tools. The digital experience is designed to anticipate customer needs and questions.
 
"Smart Web" industry-specific sites are now live for pharmaceutical, food and beverage, clinical research, environmental, forensic toxicology and fuels customers.

"We have customers across the globe, working at all hours, who are searching online for answers. We wanted to give them the same high level of support and service in the digital space that they have come to expect when working with us in person," explains Michael Garriques, Internet marketing manager at Phenomenex. "They want immediate information to help them quickly figure out which column is best for their application, purchase that column and then develop the most effective methods for their compounds. Our in-house web team has broken new ground and created an easy-to-use 'digital experience' designed to give customers the answers they need from anywhere at anytime."

In 2011, Phenomenex received the award for best biotechnology website in the Web Marketing Association's Web Award competition. The Phenomenex web tools are available across platforms and across languages including Chinese and Korean. The company has been regularly developing new web tools that enhance the user experience. Phenomenex's proprietary structure search capability, enhanced last year, enables researchers to find a method by simply drawing the chemical structure - something that is second nature to them. In addition to saving time, this approach is easy for researchers at all experience levels and, because chemical structures are universal throughout the world, it is equally convenient for users in all countries.

"Structure Search is a nice addition to your already excellent application search tools. Phenomenex has become my first web stop when searching for GC and LC applications in our lab. Kudos," commented Brandon Doss  of Algenol Biofuels.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex Chiral Screening Services Now Offered in China
Collaboration with Chinese Academy of Sciences ensures fast, high-quality screening.
Wednesday, December 05, 2012
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!